Clinical Trial Update: Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a) [Phase 1]

View source ↗

Summary

Phase 1a safety and toxicity study of intravesical instillation of TARA-002 in adults with high-grade non-muscle invasive bladder cancer. The trial has been com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• TARA-002

Snippet

Sponsor: Protara Therapeutics | Conditions: Non-muscle Invasive Bladder Cancer | Phase 1 | Status: COMPLETED